Ely Benaim Net Worth & Insider Trades
Ely Benaim - Chief Medical Officer, Novocure Ltd
What is Ely Benaim's Net Worth?
The current estimated net worth of Novocure Ltd's Chief Medical Officer, Ely Benaim, is estimated to be about $7.74M . Ely Benaim owns about 28,672 units of Novocure Ltd common stock. In the last 4 years at Novocure Ltd, Ely Benaim has sold an estimated value of $5.72M worth.
What is Ely Benaim's Past Insider Trading?
Ely Benaim's largest purchase order was 5,958 units , worth over $382.4K on April 15, 2021. Ely Benaim's largest sale order was 5,958 units , worth over $1.19M on April 15, 2021. In total, Ely Benaim has made about 24 transactions over 4 years of their time at Novocure Ltd. Ely Benaim usually trades in August, with the busiest year in 2021. The most recent transaction was a sale order of 5,959 units , worth over $439.33K on August 4, 2022.
Ely Benaim
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Ely Benaim's' Mailing Address?
- Mailing address is C/o Rexahn Pharmaceuticals, Inc. 15245 Shady Grove Road, Suite 455 Rockville MD 20850 MD
Novocure Ltd Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| William Doyle | 2020 | $772,500 | $0 | $13,893,701 | $0 | $1,053,000 | $4,500 | $15,723,701 |
| William Doyle | 2019 | $750,000 | $0 | $1,654,987 | $4,972,114 | $891,000 | $18,000 | $8,286,101 |
| William Doyle | 2018 | $750,000 | $0 | $587,505 | $2,359,400 | $843,750 | $18,000 | $4,558,655 |
| Asaf Danziger | 2020 | $781,868 | $0 | $6,946,850 | $0 | $934,607 | $293,379 | $8,956,704 |
| Asaf Danziger | 2019 | $702,295 | $0 | $1,155,020 | $4,472,183 | $693,139 | $293,970 | $7,316,607 |
| Asaf Danziger | 2018 | $692,675 | $0 | $587,505 | $2,359,400 | $644,266 | $286,448 | $4,570,294 |
| Wilhelmus Groenhuysen | 2020 | $611,400 | $250,000 | $3,666,529 | $1,827,243 | $553,500 | $29,252 | $6,937,924 |
| Wilhelmus Groenhuysen | 2019 | $600,600 | $0 | $962,485 | $2,202,814 | $396,396 | $33,789 | $4,196,084 |
| Wilhelmus Groenhuysen | 2018 | $600,600 | $0 | $489,580 | $1,966,162 | $375,375 | $27,500 | $3,459,217 |
| Ashley Cordova | 2020 | $367,175 | $300,000 | $1,374,846 | $873,201 | $318,750 | $9,277 | $3,243,249 |
| Pritesh Shah | 2020 | $481,250 | $0 | $3,333,276 | $1,661,147 | $450,000 | $14,925 | $5,940,598 |
| Pritesh Shah | 2019 | $425,000 | $0 | $867,982 | $2,027,390 | $280,500 | $73,061 | $3,673,933 |
| Pritesh Shah | 2018 | $400,000 | $0 | $768,196 | $1,616,575 | $265,625 | $20,100 | $3,070,496 |
| Todd Longsworth | 2020 | $437,500 | $300,000 | $2,666,583 | $1,328,550 | $405,000 | $11,739 | $5,149,372 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1645113/000164511321000059/nvcr-20210609xdef14a.htm
What are Novocure Ltd's Past Insider Trades?
Novocure Ltd's most recent insider trade came on March 7, 2023 by Leonard Frank X who sold 13,609 units worth $1.03M . In the last 7 years, insiders at Novocure Ltd have sold an estimated value of $590M and bought an estimated value of $141.55M worth of shares. Insider trading is most common in March, with the busiest year in 2019. The most active traders at the company are Asaf Danziger, Chief Executive Officer, Groenhuysen Wilhelmus Cm, Chief Operating Officer, and Pritesh Shah, Chief Growth Officer .
NovoCure Ltd Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||